Five years to the day after launching Chinook Therapeutics, Versant Ventures is back with a second generation of that kidney disease biotech and has a partner in Chinook’s acquirer, Novartis. The biotech incubator and investor broke the cover on Vancouver startup...
RNA Therapeutics, a clinical-stage biotechnology company focused on innovative applications of mRNA-based delivery systems for therapeutic proteins and vaccines, announced that it has received a written response to its Pre-Investigational New Drug Application...
CAMBRIDGE, Mass., March 5, 2024 /PRNewswire/ — Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage immunology company, today announced it will be providing updates on its RNA immunotherapies at multiple presentations at the American Association...
Lipid nanoparticles (LNPs) have enormous potential for the delivery of genomic medicine. One obstacle, however, is the lack of effective ways to target specific cell types. In order to target lung cells, the identification of chemically distinct lipid libraries would...
Based on the significant progress made over the last few decades with RNA therapeutics, RNA editing is widely considered the next generation of promising medicines in this field. RNA therapies have made significant progress over the last few years, with an increasing...
